On-demand Oral TDF/FTC for PrEP: Is It an Option?

preview_player
Показать описание
  1. IAS Conference on HIV Science
  2. IAS 2017
  3. IAS Conference
  4. HIV Science
  5. International AIDS Society
  6. IAS
Рекомендации по теме
On-demand Oral TDF/FTC 0:46:54

On-demand Oral TDF/FTC for PrEP: Is It an Option?

Prep for HIV 0:17:08

Prep for HIV Prevention: The 4-1-1 on 2-1-1

'On demand oral 0:57:29

'On demand oral PrEP: Is it only for French GBMSM?'

PEP to PrEP 1:32:30

PEP to PrEP Transitions: Evidence and Innovations

STD Expert Hour 0:41:51

STD Expert Hour Webinar - PrEP: What's the 2- 1-1?

On-Demand PrEP with 0:05:12

On-Demand PrEP with Dr. Antonio Urbina

Brett Tindall Memorial 0:47:51

Brett Tindall Memorial Lecture 2017: Professor Jean-michel Molina – On Demand PrEP: only for Europe...

How to Choose 0:24:37

How to Choose Between Oral and IM PrEP for Each Individual - Jean-Michel Molina, MD, PhD

Webinar: Advocates’ Debrief 1:07:20

Webinar: Advocates’ Debrief on the Science of Daily F/TAF vs TDF/FTC as PrEP

PrEP for Priority 0:49:26

PrEP for Priority Populations: Cases in HIV Prevention

HIV Prevention: What's 0:22:08

HIV Prevention: What's New? Presented by Raphael Landovitz, MD, MSc

Healthy Living with 0:59:43

Healthy Living with HIV Workshop: Session 5 | PrEP

PrEP and new 0:14:17

PrEP and new delivery systems: What does the future hold? - Raphael Landovitz, MD, MSc

PrEP 2.0: TDF/FTC 1:24:55

PrEP 2.0: TDF/FTC and Beyond – State of the Science and the Product and Delivery System Pipeline

Webinar: 'Time to 1:37:40

Webinar: 'Time to Protection' for PrEP

Intermittent PrEP Dosing 0:03:44

Intermittent PrEP Dosing For HIV Prevention | Is PrEP For Me

Implementation of Long-Acting 1:30:15

Implementation of Long-Acting PrEP: Case-Based Panel Discussion With Clinicians

Prevention of HIV 0:31:30

Prevention of HIV Infection

Session 6: PrEP 0:56:46

Session 6: PrEP and Resistance | Full Livestream

Long term impacts 0:16:40

Long term impacts of PrEP – How to reduce toxicity and resistance - Pep Coll, MD

Long acting drugs 0:26:09

Long acting drugs for PrEP - Raphael Landovitz, MD, MSc

8/1/17 On-Demand Webinar: 1:00:11

8/1/17 On-Demand Webinar: HIV Testing and Prevention (2/3) - PrEP for Cis and Transgender Women

Challenges and Opportunities 0:36:15

Challenges and Opportunities for Preexposure Prophylaxis

Evolving Use of 0:30:20

Evolving Use of Oral PrEP and Update on New Prevention Technolgies - Sinead Delany-Moretlwe

join shbcf.ru